Paradoxically, genetically modified mice with IL-18 deficiency have been reported to develop hyperphagia, obesity and insulin resistance, which might be reversed by recombinant IL-18 administration [84]. Here, IL18 is linked to hyperinsulinemic hypoglycemia, familial, 4.